Live Biotherapeutic

Advertisement

cGxPJobs Banner

Vedanta Biosciences Advances VE303 Phase 3 Trial in CDI

CAMBRIDGE, Mass., April 2, 2026 Vedanta Biosciences announced that its pivotal Phase 3 RESTORATiVE303 clinical trial of VE303 will...

By cGxPwire Editor
April 6, 2026

Read More

Advertisement

cGxPJobs

Directory